Edition:
United States

Anthem Inc (ANTM.N)

ANTM.N on New York Stock Exchange

279.15USD
19 Oct 2018
Change (% chg)

$-2.04 (-0.73%)
Prev Close
$281.19
Open
$281.09
Day's High
$282.96
Day's Low
$278.57
Volume
438,537
Avg. Vol
315,317
52-wk High
$282.96
52-wk Low
$187.75

Chart for

About

Anthem, Inc. is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred... (more)

Overall

Beta: 0.76
Market Cap(Mil.): $50,736.61
Shares Outstanding(Mil.): 262.58
Dividend: 0.70
Yield (%): 1.45

Financials

  ANTM.N Industry Sector
P/E (TTM): 18.28 23.99 33.64
EPS (TTM): 10.57 -- --
ROI: -- -0.02 14.27
ROE: 11.26 16.38 15.99

Takeda gets Japanese approval for $62 billion Shire purchase

Takeda Pharmaceutical Co Ltd said on Thursday Japan's Fair Trade Commission had approved its $62 billion acquisition of Shire Plc , bringing the Japanese firm closer to sealing a deal that will make it a global top 10 drugmaker.

Oct 18 2018

UPDATE 1-Takeda gets Japanese approval for $62 bln Shire purchase

Oct 18 Takeda Pharmaceutical Co Ltd said on Thursday Japan's Fair Trade Commission had approved its $62 billion acquisition of Shire Plc, bringing the Japanese firm closer to sealing a deal that will make it a global top 10 drugmaker.

Oct 18 2018

Takeda gets Japan's approval for $62 bln Shire purchase

Oct 18 Takeda Pharmaceutical Co Ltd said on Thursday Japan's Fair Trade Commission had approved its $62 billion acquisition of Shire Plc, bringing the Japanese firm closer to sealing a deal that will make it a global top 10 drugmaker.

Oct 18 2018

Louisiana wins revival of lawsuit against Takeda over Actos cancer risks

A Louisiana appellate court has revived a lawsuit by the state's attorney general accusing Takeda Pharmaceutical Co Ltd of engaging in a fraudulent campaign to mislead the state about the risks of cancer associated with its diabetes drug Actos.

Oct 04 2018

Deal-making spree keeps investors upbeat about European M&A revival

MILAN, Sept 26 The $40 billion takeover of British broadcaster Sky and other new deals in Europe have broken a summer lull to bolster investor optimism over an M&A revival in the region.

Sep 26 2018

Anthem ties-up with Walmart for over-the-counter drugs

Anthem Inc said on Monday it has partnered with Walmart Inc to launch a program in January 2019 that will allow its Medicare Advantage plan customers to purchase over-the-counter medications from the retailer's stores and website.

Aug 20 2018

Anthem ties-up with Walmart for over-the-counter drugs

Aug 20 Anthem Inc said on Monday it has partnered with Walmart Inc to launch a program in January 2019 that will allow its Medicare Advantage plan customers to purchase over-the-counter medications from the retailer's stores and website.

Aug 20 2018

Insurer Anthem profit beats estimates on lower patient costs

Anthem Inc reported a better-than-expected profit on Wednesday, driven by higher premiums and lower patient medical costs even as fewer people enrolled in its insurance plans.

Jul 25 2018

UPDATE 4-Insurer Anthem profit beats estimates on lower patient costs

July 25 Anthem Inc reported a better-than-expected profit on Wednesday, driven by higher premiums and lower patient medical costs even as fewer people enrolled in its insurance plans.

Jul 25 2018

U.S. health insurer Anthem quarterly profit rises 23 pct

July 25 Anthem Inc reported a 23 percent rise in quarterly profit on Wednesday, helped by premium rate increases.

Jul 25 2018

Competitors

  Price Chg
Humana Inc (HUM.N) $328.38 -3.93
Aetna Inc (AET.N) $200.19 -1.30
Magellan Health Inc (MGLN.OQ) $66.78 -0.82
CIGNA Corporation (CI.N) $210.00 -2.74
UnitedHealth Group Inc (UNH.N) $265.30 -1.51

Earnings vs. Estimates